Colgate-Palmolive Q1 sales beat estimates on broad-based growth

كولغيت بالموليف كو

Colgate-Palmolive Company

CL

0.00


Overview

  • Consumer products maker's Q1 net sales rose 8.4%, beating analyst expectations

  • Adjusted EPS for Q1 grew 7% and beat analyst expectations

  • Company expanded Strategic Growth and Productivity Program, raising projected charges and savings


Outlook

  • Colgate-Palmolive maintains 2026 net sales growth guidance of 2% to 6%

  • Company now expects 2026 gross profit margin to be down, versus up previously

  • Colgate-Palmolive expects volatile macroeconomic conditions and slower category growth to continue in 2026


Result Drivers

  • BROAD-BASED SALES GROWTH - Co said net and organic sales grew in every category and in four of five divisions, with both pricing and volume contributing

  • PRIVATE LABEL PET FOOD EXIT - Organic sales growth was negatively affected by lower private label pet food sales

  • HIGHER ADVERTISING SPENDING - Advertising spending increased year over year


Company press release: ID:nBw1SbSpda


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Sales

Beat

$5.32 bln

$5.22 bln (12 Analysts)

Q1 Adjusted EPS

Beat

$0.97

$0.95 (16 Analysts)

Q1 EPS

$0.80


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 8 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the personal products peer group is "buy"

  • Wall Street's median 12-month price target for Colgate-Palmolive Co is $98.00, about 14.8% above its April 30 closing price of $85.36

  • The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 23 three months ago


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.